We use these DEXA insights to design, adjust, and refine your protocol over time, whether youre pursuing hormone optimization, peptide therapy, or medical weight loss
Characterized Signaling Pathways Published research has identified multiple cellular signaling interactions: Nitric Oxide Signaling (eNOS) Research by Hsieh et al
Think of this as "noise-canceling headphones" for your eyes
Peptide transformations typically preserve more lean mass compared to diet-only approaches, though dedicated resistance training remains essential for optimizing body composition outcomes
IC + RL rats) and later (IC + OB rats) periods, and may be triggered shortly after injury initiation [IC rats (vessels ligation)]
Read review Dihexa for Autism Spectrum Disorder (ASD) The Campbell rs1858830 MET promoter C-allele autism finding (the strongest mechanistic anchor to Dihexa pharmacology), the January 2026 mGluR5 PET 16-23% lower availability, the December 2025 DAYBUE STIX (trofinetide) Rett approval, the March 2026 FDA leucovorin decision (CFD only, not autism), the 270,701 NHS open referrals breaching NICE NG142, and the ~700,000 UK autistic population